Skip to main content

Table 3 Gender differences in the attainment of guideline recommendations, separately for MI and stroke

From: Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis

  MI only Stroke only
Men (n = 9455) Women (n = 5560) p* Men (n = 5883) Women (n = 5855) p*
HbA1C <7.5 %, % 65.8 64.1 0.0553 62.2 61.4 0.4082
Blood pressure <130/80 (mmHg), % 67.4 66.5 0.2679
Blood pressure 120/70–140/90 (mmHg), % 90.0 89.5 0.1583
LDL-cholesterol <100 (mg/dl),  % 60.1 49.2 <0.0001 46.1 38.3 <0.0001
BMI <27 (kg/m2),  % 33.5 28.6 <0.0001  
Inhibitors of platelet aggregation, % 51.3 49.4 0.0137 32.7 30.5 0.0118
Statins, % 58.5 54.5 <0.0001 42.0 38.2 <0.0001
ACE inhibitors, % 51.3 46.9 <0.0001 42.2 40.3 0.0414
Beta blockers, % 59.7 59.0 0.4290
Any type of antihypertensives, % 65.9 63.8 0.0115 65.1 66.7 0.0684
Non-smoker, % 92.0 94.0 <0.0001 92.4 95.3 <0.0001
Physically active, % 9.5 8.5 0.2201 5.8 4.7 0.0887
  1. * Data adjusted for age-groups (20–<65, 65–<75, >75 years of age)